Home Page ::: CNS & Neurological Disorders - Drug Targets

ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)


Volume 15, 10 Issues, 2016


Download PDF Flyer




CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 107th of 254 in

    Pharmacology & Pharmacy


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Stephen D. Skaper


Department of Pharmaceutical and Pharmacological Sciences
University of Padova
Padova
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.628
5 - Year: 3.148
Browse Contents
Select Volume:


Select Issue:


Select Article:



Endorsement(s)

"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Forthcoming Special Issue(s)

ASSOCIATION OF CNS DISORDERS WITH OTHER HEALTH ISSUES


Guest Editor(s): Mohammad A. Kamal
Tentative Publication Date: August, 2016
Submit Abstract via Email Download Description
Special Issue(s) - In-Press
Published Special Issue(s)

MiRNAcles In The Brain: What To Wish And What To Fear


Guest Editor(s): Stephen D. Skaper, Cinzia Volonté
Download Description
Authors' Comments
I am extremely grateful for working with Bentham Science. In my opinion, it is one of the best publishers.

Gjumrakch Aliev, MD & PhD
(President "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA)

Has contributed: Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound

CNS & Neurological Disorders - Drug Targets

,

Volume 15

-

Number 1



Advertisement
16TH ANNUAL PAIN THERAPEUTICS

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science